TY  - BOOK
AU  - Haider Yousif Hameed Shukur
AU  - Amr Yehia Sakr , 
AU  - Ehsan Gamal Eldin Elghonemy , 
AU  - Hanan Selim Mosalem , 
TI  - Efficacy and tolerability of folfirinox in treatment of advanced pancreatic cancer patients / 
PY  - 2013///
CY  - Cairo : 
PB  - Haider Yousif Hameed Shukur , 
KW  - FOLFIRINOX
KW  - Gemcitabine
KW  - vs
N1  - Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Oncology-Clinical; Issued also as CD
N2  - In compares of FOLFIRINOX to Gemciabine group according to treatment line, we find that the ORR to FOLFIRINOX was 45% versus 10% in Gemcitabine arm also overall survival was 11 months versus 7 months although the toxicity of this protocol was greater than Gemcitabine, but all was manageable and tolerable
ER  -